Related Experiment Video
Updated: Oct 11, 2026

In Vivo SiRNA Transfection and Gene Knockdown in Spinal Cord via Rapid Noninvasive Lumbar Intrathecal Injections in Mice
Published on: March 22, 2014
Hypogonadism in patients treated with intrathecal morphine
P M Finch1, L J Roberts, L Price
1Perth Pain Management Centre, South Perth, Western Australia. pfinch@iinet.net.au
Objective:
The objective of this study was to investigate the hypothalamic-pituitary-gonadal response to intrathecal opioids.
Patients:
Thirty patients receiving intrathecal morphine for chronic nonmalignant pain were studied for clinical and biochemical evidence of hypogonadism. Ten men and 10 postmenopausal women with chronic pain of similar duration but who were not receiving any form of opioid therapy acted as control subjects.
Results:
Men and both premenopausal and postmenopausal women had evidence of hypogonadism with low levels of serum testosterone or estrogen coupled with low levels of pituitary gonadotrophins. Control subjects had hormone levels in the expected range for their sex and age. Two men demonstrated recovery after ceasing intrathecal opioid therapy.
Conclusions:
Hypogonadotrophic hypogonadism is a common complication of intrathecal opioid therapy in both men and women.
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Analgesia and Pain Management
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Receptors: Overview

